175 - The biology of aging, rapamycin, and other interventions that target the aging process
Peter Attia MD
A catalytic (ATP competitive) inhibitor of mTOR that theoretically inhibits both mTORC1 and mTORC2, showing potential in mitochondrial disease models, but not yet tested for aging effects in mice lifespan studies.
